C-Myc Knockdown Restores Tamoxifen Sensitivity in Triple-Negative Breast Cancer by Reactivating the Expression of ERα: The Central Role of miR-152 and miR-148a

Researchers illustrated that c-Myc knockdown in triple-negative breast cancer (TNBC) cells reactivate ERα expression in a miR-152/miR-148a-DNMT1-dependent manner, and brought new sights into treating TNBC using hormonal therapies.